{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:25:57Z","timestamp":1787286357177,"version":"build-2736575974"},"reference-count":109,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011528","name":"Phase One Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011528","id-type":"DOI","asserted-by":"publisher"}]},{"id":[{"id":"https:\/\/ror.org\/010p1tc53","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Renal cell carcinoma (RCC) is frequently detected incidentally, and no widely adopted noninvasive biomarkers are available for RCC diagnosis or prognosis. In this regard, cell-free microRNAs (cfmiRs) have emerged as promising candidates due to their stability in biological fluids. In this narrative review, we summarize translational studies published from 2010 to 2025 that evaluated serum, plasma, or urinary cfmiRs for RCC diagnosis, prognosis, recurrence surveillance, or treatment-response monitoring. Forty-two studies met inclusion criteria, comprising 3454 patients with RCC and 2445 healthy donors. Twenty-nine studies assessed diagnostic performance, fewer evaluated prognostic applications, and none examined treatment-response monitoring. Multi-miRNA panels generally reported higher performance than single-miRNA assays. Serum was the most frequently studied biofluid in this review (n = 26), followed by urine (n = 12) and plasma (n = 4). Urinary biomarkers demonstrated high specificity and the practical advantage of noninvasive collection. Although limited in number, prognostic studies identified associations between cfmiRs and overall survival, recurrence-free survival, metastasis-free survival, and other clinically relevant outcomes. However, substantial heterogeneity in study design, assay methods, and reporting limited comparisons across studies. Current evidence supports continued evaluation of cfmiRs as adjunctive biomarkers alongside imaging or histopathology, but multicenter validation, standardized methods, and more robust evidence are required before clinical implementation.<\/jats:p>","DOI":"10.3390\/cells15161485","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:12:11Z","timestamp":1787069531000},"page":"1485","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urine and Blood-Derived MicroRNAs in Patients with Kidney Cancer: A Review of Clinical Utility and Recent Developments"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7054-6108","authenticated-orcid":false,"given":"Samuel Y. R.","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Translational and Precision Medicine, Saint John\u2019s Cancer Institute (SJCI), Providence Saint John\u2019s Health Center (SJHC), Santa Monica, CA 90404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7474-2792","authenticated-orcid":false,"given":"Serina","family":"Quach","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Saint John\u2019s Cancer Institute (SJCI), Providence Saint John\u2019s Health Center (SJHC), Santa Monica, CA 90404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3412-184X","authenticated-orcid":false,"given":"Vladislav","family":"Nikitin","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Saint John\u2019s Cancer Institute (SJCI), Providence Saint John\u2019s Health Center (SJHC), Santa Monica, CA 90404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Linehan","sequence":"additional","affiliation":[{"name":"Department of Urology and Urologic Oncology, Saint John\u2019s Cancer Institute (SJCI), Providence Saint John\u2019s Health Center (SJHC), Santa Monica, CA 90404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9625-1127","authenticated-orcid":false,"given":"Matias A.","family":"Bustos","sequence":"additional","affiliation":[{"name":"Department of Translational and Precision Medicine, Saint John\u2019s Cancer Institute (SJCI), Providence Saint John\u2019s Health Center (SJHC), Santa Monica, CA 90404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"ref_1","first-page":"e70043","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Mattila, K.E., Vainio, P., and Jaakkola, P.M. (2022). Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy. Cancers, 14.","DOI":"10.3390\/cancers14010239"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/ndt\/gfac177","article-title":"The risks associated with percutaneous native kidney biopsies: A prospective study","volume":"38","author":"Andrulli","year":"2023","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.juro.2015.11.029","article-title":"Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the Literature","volume":"195","author":"Patel","year":"2016","journal-title":"J. Urol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/JU.0000000000001912","article-title":"Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II","volume":"206","author":"Campbell","year":"2021","journal-title":"J. Urol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1016\/j.clgc.2023.10.003","article-title":"Urinary miRNAs Predict Metastasis in Patients with Clinically Localized Clear Cell Renal Cell Carcinoma Treated with Nephrectomy","volume":"22","author":"Shu","year":"2024","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"18135","DOI":"10.1038\/s41598-025-01225-6","article-title":"A panel of three serum microRNAs as a potential diagnostic biomarker for renal cell carcinoma","volume":"15","author":"Lin","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12935-023-03187-z","article-title":"A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma","volume":"24","author":"Wen","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clgc.2023.07.002","article-title":"Profiling of Serum miRNAs Constructs a Diagnostic 3-miRNA Panel for Clear-Cell Renal Cell Carcinoma","volume":"22","author":"Li","year":"2024","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12672-023-00730-2","article-title":"Serum extracellular vesicles derived hsa-miR-320d as an indicator for progression of clear cell renal cell carcinoma","volume":"14","author":"Xue","year":"2023","journal-title":"Discov. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Li, R., Chen, W., Lu, C., Li, X., Chen, X., Huang, G., Wen, Z., Li, H., Tao, L., and Hu, Y. (2023). A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1076303"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Li, R., Lu, C., Li, X., Chen, X., Huang, G., Wen, Z., Li, H., Tao, L., Hu, Y., and Zhao, Z. (2022). A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.897827"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"153625","DOI":"10.1016\/j.prp.2021.153625","article-title":"Identification of a four-microRNA panel in serum for screening renal cell carcinoma","volume":"227","author":"Chen","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.21873\/cgp.20256","article-title":"Profiling of Serum Extracellular Vesicles Reveals miRNA-4525 as a Potential Biomarker for Advanced Renal Cell Carcinoma","volume":"18","author":"Kawakami","year":"2021","journal-title":"Cancer Genom. Proteom."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"153152","DOI":"10.1016\/j.prp.2020.153152","article-title":"Combination of tumor suppressor miR-20b-5p, miR-30a-5p, and miR-196a-5p as a serum diagnostic panel for renal cell carcinoma","volume":"216","author":"Huang","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.21037\/tau.2020.03.18","article-title":"Identification of miR-21-5p and miR-210-3p serum levels as biomarkers for patients with papillary renal cell carcinoma: A multicenter analysis","volume":"9","author":"Kalogirou","year":"2020","journal-title":"Transl. Androl. Urol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s12253-020-00842-y","article-title":"A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma","volume":"26","author":"Huang","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"ref_18","first-page":"5075","article-title":"Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma","volume":"20","author":"Liu","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/jcb.27347","article-title":"Serum exosomal miR-210 as a potential biomarker for clear cell renal cell carcinoma","volume":"120","author":"Wang","year":"2019","journal-title":"J. Cell Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13148-018-0444-9","article-title":"Serum miR-122-5p and miR-206 expression: Non-invasive prognostic biomarkers for renal cell carcinoma","volume":"10","author":"Heinemann","year":"2018","journal-title":"Clin. Epigenet."},{"key":"ref_21","first-page":"1428","article-title":"MiR429 expression level in renal cell cancer and its correlation with the prognosis of patients","volume":"22","author":"Wang","year":"2017","journal-title":"J. BUON"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.euf.2016.09.007","article-title":"MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma","volume":"4","author":"Zhang","year":"2018","journal-title":"Eur. Urol. Focus"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/CBM-160676","article-title":"Functional analysis of serum microRNAs miR-21 and miR-106a in renal cell carcinoma","volume":"18","author":"Tusong","year":"2017","journal-title":"Cancer Biomark."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.urology.2017.03.013","article-title":"Serum microRNA Expression Profiling: Potential Diagnostic Implications of a Panel of Serum microRNAs for Clear Cell Renal Cell Cancer","volume":"104","author":"Yadav","year":"2017","journal-title":"Urology"},{"key":"ref_25","first-page":"15017746","article-title":"Expression of microRNA-210 in tissue and serum of renal carcinoma patients and its effect on renal carcinoma cell proliferation, apoptosis, and invasion","volume":"15","author":"Liu","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"23382","DOI":"10.3390\/ijms161023382","article-title":"Combination of MiR-378 and MiR-210 Serum Levels Enables Sensitive Detection of Renal Cell Carcinoma","volume":"16","author":"Fedorko","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1038\/srep07610","article-title":"A panel of five serum miRNAs as a potential diagnostic tool for early-stage renal cell carcinoma","volume":"5","author":"Wang","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3892\/ijo.2013.2169","article-title":"Serum miR-210 as a potential biomarker of early clear cell renal cell carcinoma","volume":"44","author":"Iwamoto","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.yexmp.2012.10.005","article-title":"Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma","volume":"94","author":"Zhao","year":"2013","journal-title":"Exp. Mol. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.canep.2012.04.001","article-title":"Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma","volume":"36","author":"Hauser","year":"2012","journal-title":"Cancer Epidemiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1479-5876-10-55","article-title":"Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma","volume":"10","author":"Redova","year":"2012","journal-title":"J. Transl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Wulfken, L.M., Moritz, R., Ohlmann, C., Holdenrieder, S., Jung, V., Becker, F., Herrmann, E., Walgenbach-Br\u00fcnagel, G., von Ruecker, A., and M\u00fcller, S.C. (2011). MicroRNAs in renal cell carcinoma: Diagnostic implications of serum miR-1233 levels. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025787"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/clinchem\/hvad133","article-title":"Diagnostic miRNA Signatures in Paired Tumor, Plasma, and Urine Specimens from Renal Cell Carcinoma Patients","volume":"70","author":"Bustos","year":"2024","journal-title":"Clin. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Sequeira, J.P., Barros-Silva, D., Ferreira-Torre, P., Salta, S., Braga, I., Carvalho, J., Freitas, R., Henrique, R., and Jer\u00f3nimo, C. (2023). OncoUroMiR: Circulating miRNAs for Detection and Discrimination of the Main Urological Cancers Using a ddPCR-Based Approach. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241813890"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Sequeira, J.P., Const\u00e2ncio, V., Salta, S., Lobo, J., Barros-Silva, D., Carvalho-Maia, C., Rodrigues, J., Braga, I., Henrique, R., and Jer\u00f3nimo, C. (2022). LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma. Cancers, 14.","DOI":"10.3390\/cancers14040858"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/ijc.30845","article-title":"Large-scale genome-wide screening of circulating microRNAs in clear cell renal cell carcinoma reveals specific signatures in late-stage disease","volume":"141","author":"Chanudet","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Cochetti, G., Cari, L., Maul\u00e0, V., Cagnani, R., Paladini, A., Del Zingaro, M., Nocentini, G., and Mearini, E. (2022). Validation in an Independent Cohort of MiR-122, MiR-1271, and MiR-15b as Urinary Biomarkers for the Potential Early Diagnosis of Clear Cell Renal Cell Carcinoma. Cancers, 14.","DOI":"10.3390\/cancers14051112"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Oto, J., Herranz, R., Plana, E., S\u00e1nchez-Gonz\u00e1lez, J.V., P\u00e9rez-Ardav\u00edn, J., Herv\u00e1s, D., Fern\u00e1ndez-Pardo, \u00c1., Cana, F., Vera-Donoso, C.D., and Mart\u00ednez-Sarmiento, M. (2021). Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22157913"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"21290","DOI":"10.1038\/s41598-020-77774-9","article-title":"Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma","volume":"10","author":"Cochetti","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-020-01600-3","article-title":"MicroRNA-30a-5p(me): A novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples","volume":"39","author":"Aznar","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3233\/CBM-190242","article-title":"Emerging role of secreted miR-210-3p as potential biomarker for clear cell Renal Cell Carcinoma metastasis","volume":"27","author":"Petrozza","year":"2020","journal-title":"Cancer Biomark."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.1111\/jcmm.14553","article-title":"Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5","volume":"23","author":"Song","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s11255-018-1841-x","article-title":"MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma","volume":"50","author":"Mytsyk","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"69551","DOI":"10.18632\/oncotarget.18449","article-title":"Secreted miR-210-3p as non-invasive biomarker in clear cell renal cell carcinoma","volume":"8","author":"Petrozza","year":"2017","journal-title":"Oncotarget"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.11613\/BM.2017.043","article-title":"Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma","volume":"27","author":"Fedorko","year":"2017","journal-title":"Biochem. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.urolonc.2016.12.007","article-title":"Detection of urinary cell-free miR-210 as a potential tool of liquid biopsy for clear cell renal cell carcinoma","volume":"35","author":"Li","year":"2017","journal-title":"Urol. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7754\/Clin.Lab.2017.171103","article-title":"Detection Performance of Circulating MicroRNA-210 for Renal Cell Carcinoma: A Meta-Analysis","volume":"64","author":"Chen","year":"2018","journal-title":"Clin. Lab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/CMR.0000000000000450","article-title":"Serum exosomal microRNAs as potent circulating biomarkers for melanoma","volume":"28","author":"Tengda","year":"2018","journal-title":"Melanoma. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.7754\/Clin.Lab.2019.190422","article-title":"Increased Expression of miR-494 in Serum of Patients with Prostate Cancer and its Potential Diagnostic Value","volume":"65","author":"Cai","year":"2019","journal-title":"Clin. Lab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3233\/CBM-182213","article-title":"Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer","volume":"24","author":"Kong","year":"2019","journal-title":"Cancer Biomark."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Loosen, S.H., Lurje, G., Wiltberger, G., Vucur, M., Koch, A., Kather, J.N., Paffenholz, P., Tacke, F., Ulmer, F.T., and Trautwein, C. (2019). Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210944"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.7754\/Clin.Lab.2019.190416","article-title":"Combined use of Serum miR-499a-5p and CA199 Increases the Diagnostic Sensitivity of Pancreatic Cancer","volume":"65","author":"Shi","year":"2019","journal-title":"Clin. Lab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1158\/1078-0432.CCR-18-1414","article-title":"Serum miRNA-based Prediction of Axillary Lymph Node Metastasis in Breast Cancer","volume":"25","author":"Shiino","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/CBM-182129","article-title":"Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer","volume":"24","author":"Sun","year":"2019","journal-title":"Cancer Biomark."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e1217","DOI":"10.1016\/j.wneu.2019.02.009","article-title":"Diagnostic and Prognostic Potential of Serum Cell-Free microRNA-214 in Glioma","volume":"125","author":"Wang","year":"2019","journal-title":"World Neurosurg."},{"key":"ref_56","first-page":"8345","article-title":"Reduced serum miR-98 predicts unfavorable clinical outcome of colorectal cancer","volume":"23","author":"Wang","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3233\/CBM-181416","article-title":"Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients","volume":"24","author":"Zhang","year":"2019","journal-title":"Cancer Biomark."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1002\/cam4.2145","article-title":"Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis","volume":"8","author":"Zou","year":"2019","journal-title":"Cancer Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"300060519896144","DOI":"10.1177\/0300060519896144","article-title":"Decreased serum exosomal miR-320a expression is an unfavorable prognostic factor in patients with hepatocellular carcinoma","volume":"48","author":"Hao","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1533033820973276","DOI":"10.1177\/1533033820973276","article-title":"Serum miR-185 Is a Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer","volume":"19","author":"Liu","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11060-020-03566-w","article-title":"Serum microRNA is a biomarker for post-operative monitoring in glioma","volume":"149","author":"Morokoff","year":"2020","journal-title":"J. Neurooncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10147-019-01532-9","article-title":"Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer","volume":"25","author":"Shi","year":"2020","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cca.2020.03.005","article-title":"Serum miR-338-3p and miR-199b-5p are associated with the absolute neutrophil count in patients with resectable pancreatic cancer","volume":"505","author":"Vietsch","year":"2020","journal-title":"Clin. Chim. Acta."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"25036","DOI":"10.1073\/pnas.2006212117","article-title":"Development of a serum miRNA panel for detection of early stage non-small cell lung cancer","volume":"117","author":"Ying","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1177\/1535370220945987","article-title":"Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early-stage non-small cell lung cancer","volume":"245","author":"Zhang","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"BSR20210111","DOI":"10.1042\/BSR20210111","article-title":"MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer","volume":"41","author":"Fan","year":"2021","journal-title":"Biosci. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"23756","DOI":"10.1038\/s41598-021-03222-x","article-title":"Detection of increased serum miR-122-5p and miR-455-3p levels before the clinical diagnosis of liver cancer in people with type 2 diabetes","volume":"11","author":"Lee","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2217\/fon-2020-0792","article-title":"Circulating serum exosomal miR-92a-3p as a novel biomarker for early diagnosis of gastric cancer","volume":"17","author":"Lu","year":"2021","journal-title":"Future Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Olioso, D., Caccese, M., Santangelo, A., Lippi, G., Zagonel, V., Cabrini, G., Lombardi, G., and Dechecchi, M.C. (2021). Serum Exosomal microRNA-21, 222 and 124-3p as Noninvasive Predictive Biomarkers in Newly Diagnosed High-Grade Gliomas: A Prospective Study. Cancers, 13.","DOI":"10.3390\/cancers13123006"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3233\/CBM-201547","article-title":"MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis","volume":"30","author":"Zou","year":"2021","journal-title":"Cancer Biomark."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2217\/fon-2021-1130","article-title":"Serum exosomal miR-377-3p and miR-381-3p as diagnostic biomarkers in colorectal cancer","volume":"18","author":"Wang","year":"2022","journal-title":"Future Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Wroblewska, J.P., Lach, M.S., Rucinski, M., Piotrowski, I., Galus, L., Suchorska, W.M., Kreis, S., and Marszalek, A. (2022). MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.1008901"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"154320","DOI":"10.1016\/j.prp.2023.154320","article-title":"Circulating microRNAs in gallbladder cancer: Is serum assay of diagnostic value?","volume":"242","author":"Srivastava","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Cochetti, G., Guadagni, L., Paladini, A., Russo, M., La Mura, R., Vitale, A., Saqer, E., Mangione, P., Esposito, R., and Gio\u00e8, M. (2025). Evaluation of Urinary miRNA in Renal Cell Carcinoma: A Systematic Review. Cancers, 17.","DOI":"10.3390\/cancers17081336"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Motshwari, D.D., Matshazi, D.M., Erasmus, R.T., Kengne, A.P., Matsha, T.E., and George, C. (2023). MicroRNAs Associated with Chronic Kidney Disease in the General Population and High-Risk Subgroups-A Systematic Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021792"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Carmona, A., Guerrero, F., Jimenez, M.J., Ariza, F., Ag\u00fcera, M.L., Obrero, T., Noci, V., Mu\u00f1oz-Casta\u00f1eda, J.R., Rodr\u00edguez, M., and Soriano, S. (2020). Inflammation, Senescence and MicroRNAs in Chronic Kidney Disease. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00739"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1038\/s41598-019-41101-8","article-title":"Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients","volume":"9","author":"Fourdinier","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Fujii, R., Yamada, H., Yamazaki, M., Munetsuna, E., Ando, Y., Ohashi, K., Ishikawa, H., Shimoda, H., Sakata, K., and Ogawa, A. (2019). Circulating microRNAs (miR-126, miR-197, and miR-223) are associated with chronic kidney disease among elderly survivors of the Great East Japan Earthquake. BMC Nephrol., 20.","DOI":"10.1186\/s12882-019-1651-0"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2016.11.016","article-title":"MicroRNAs 223-3p and 93-5p in patients with chronic kidney disease before and after renal transplantation","volume":"95","author":"Ulbing","year":"2017","journal-title":"Bone"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Chen, N.X., Kiattisunthorn, K., O\u2019Neill, K.D., Chen, X., Moorthi, R.N., Gattone, V.H., Allen, M.R., and Moe, S.M. (2013). Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0064558"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s11255-021-02928-1","article-title":"Analysis of profibrogenic microRNAs (miRNAs) expression in urine and serum of chronic kidney disease (CKD) stage 1-4 patients and their relationship with proteinuria and kidney function","volume":"54","author":"Donderski","year":"2022","journal-title":"Int. Urol. Nephrol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000458711","article-title":"MicroRNA-155 and Anti-M\u00fcllerian Hormone: New Potential Markers of Subfertility in Men with Chronic Kidney Disease","volume":"7","author":"Eckersten","year":"2017","journal-title":"Nephron. Extra."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7754\/Clin.Lab.2019.190209","article-title":"Expression Level of Circulating Cell Free miR-155 Gene in Serum of Patients with Diabetic Nephropathy","volume":"65","author":"Akhbari","year":"2019","journal-title":"Clin. Lab."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Barutta, F., Tricarico, M., Corbelli, A., Annaratone, L., Pinach, S., Grimaldi, S., Bruno, G., Cimino, D., Taverna, D., and Deregibus, M.C. (2013). Urinary exosomal microRNAs in incipient diabetic nephropathy. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0073798"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5204394","DOI":"10.1155\/2019\/5204394","article-title":"Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy","volume":"2019","author":"Wang","year":"2019","journal-title":"J. Diabetes. Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1111\/jcmm.14317","article-title":"MiR-21 is up-regulated in urinary exosomes of chronic kidney disease patients and after glomerular injury","volume":"23","author":"Lange","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.2337\/db18-1360","article-title":"Diabetic Nephropathy Alters the Distribution of Circulating Angiogenic MicroRNAs Among Extracellular Vesicles, HDL, and Ago-2","volume":"68","author":"Florijn","year":"2019","journal-title":"Diabetes"},{"key":"ref_88","first-page":"21","article-title":"MicroRNA-21 as an early marker of nephropathy in patients with type 1 diabetes","volume":"30","author":"Fouad","year":"2019","journal-title":"Indian J. Nephrol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/jim-2017-000556","article-title":"Deregulated profiles of urinary microRNAs may explain podocyte injury and proximal tubule dysfunction in normoalbuminuric patients with type 2 diabetes mellitus","volume":"66","author":"Milas","year":"2018","journal-title":"J. Investig. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2217\/bmm-2019-0124","article-title":"Interleukins and miRNAs intervene in the early stages of diabetic kidney disease in Type 2 diabetes mellitus patients","volume":"13","author":"Petrica","year":"2019","journal-title":"Biomark. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"10900","DOI":"10.1038\/s41598-019-47504-x","article-title":"Differential Expression of Urinary Exosomal MicroRNAs miR-21-5p and miR-30b-5p in Individuals with Diabetic Kidney Disease","volume":"9","author":"Zang","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00125-014-3282-0","article-title":"MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1","volume":"57","author":"He","year":"2014","journal-title":"Diabetologia"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"110407","DOI":"10.1016\/j.ygeno.2022.110407","article-title":"Plasma and urinary extracellular vesicle microRNAs and their related pathways in diabetic kidney disease","volume":"114","author":"Park","year":"2022","journal-title":"Genom."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"343440","DOI":"10.1016\/j.aca.2024.343440","article-title":"Multiplex digital PCR for the simultaneous quantification of a miRNA panel","volume":"1335","author":"Busato","year":"2025","journal-title":"Anal. Chim. Acta."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1017\/erm.2025.2","article-title":"Review of microRNA detection workflows from liquid biopsy for disease diagnostics","volume":"27","author":"Naranbat","year":"2025","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"9614","DOI":"10.1097\/JS9.0000000000004721","article-title":"S12micro: A machine learning-derived serum miRNA panel for high-performance pan-cancer diagnosis via liquid biopsy","volume":"112","author":"Long","year":"2026","journal-title":"Int. J. Surg."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"16393","DOI":"10.1038\/s41598-022-20783-7","article-title":"Panels of mRNAs and miRNAs for decoding molecular mechanisms of Renal Cell Carcinoma (RCC) subtypes utilizing Artificial Intelligence approaches","volume":"12","author":"Ardalan","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/path.2860","article-title":"Overexpression of miR-210, a downstream target of HIF1\u03b1, causes centrosome amplification in renal carcinoma cells","volume":"224","author":"Nakada","year":"2011","journal-title":"J. Pathol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"20881","DOI":"10.18632\/oncotarget.14930","article-title":"microRNA-210-3p depletion by CRISPR\/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma","volume":"8","author":"Yoshino","year":"2017","journal-title":"Oncotarget"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.cellsig.2013.08.005","article-title":"NF\u03baB-mediated cyclin D1 expression by microRNA-21 influences renal cancer cell proliferation","volume":"25","author":"Bera","year":"2013","journal-title":"Cell Signal"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-20-0832","article-title":"A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis","volume":"81","author":"Kulkarni","year":"2021","journal-title":"Cancer Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10863-021-09901-8","article-title":"Circ_RPL23A acts as a miR-1233 sponge to suppress the progression of clear cell renal cell carcinoma by promoting ACAT2","volume":"53","author":"Cheng","year":"2021","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_103","first-page":"2207","article-title":"MiR-378a-5p acts as a tumor suppressor in renal cell carcinoma and is associated with the good prognosis of patients","volume":"11","author":"Pan","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Puia, D., Iv\u0103nu\u021b\u0103, M., and Pricop, C. (2025). Kidney Injury Molecule-1 as a Biomarker for Renal Cancer: Current Insights and Future Perspectives-A Narrative Review. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26073431"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41591-025-04067-x","article-title":"Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma","volume":"32","author":"Machaalani","year":"2026","journal-title":"Nat. Med."},{"key":"ref_106","first-page":"8","article-title":"What\u2019s new in the WHO 2022 classification of kidney tumours?","volume":"115","author":"Alaghehbandan","year":"2022","journal-title":"Pathologica"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"020501","DOI":"10.11613\/BM.2024.020501","article-title":"Preanalytical, analytical and postanalytical considerations in circulating microRNAs measurement","volume":"34","author":"Zendjabil","year":"2024","journal-title":"Biochem. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"32651","DOI":"10.1038\/srep32651","article-title":"Platelets confound the measurement of extracellular miRNA in archived plasma","volume":"6","author":"Mitchell","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e12158","DOI":"10.1002\/jev2.12158","article-title":"Urinary extracellular vesicles: Assessment of pre-analytical variables and development of a quality control with focus on transcriptomic biomarker research","volume":"10","author":"Barreiro","year":"2021","journal-title":"J. Extracell. Vesicles"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/16\/1485\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T04:12:56Z","timestamp":1787285576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/16\/1485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":109,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cells15161485"],"URL":"https:\/\/doi.org\/10.3390\/cells15161485","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}